Bridget A. Ross is Director at LEMAITRE VASCULAR INC (LMAT). They have made 7 open-market trades across 1 company since 2023, most recently 2026-05-07.
CIK 0001698518
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HSIC | 9,654 | $834K |
| LMAT | 3,942 | $319K |
| Total | $1.2M |
Shares reported on the most recent Form 4, priced at the 2026-05-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LMAT | SELL | 2026-05-07 | 2026-05-11 | $111.10 | $560K | -1.5% | -8.6% | -19.7% |
| LMAT | SELL | 2025-08-08 | 2025-08-13 | $94.00 | $235K | +3.1% | -2.5% | -4.5% |
| LMAT | SELL | 2025-05-12 | 2025-05-14 | $83.20 | $312K | -0.3% | -2.2% | +13.8% |
| LMAT | SELL | 2024-11-15 | 2024-11-19 | $101.47 | $761K | +1.9% | -10.9% | -2.7% |
| LMAT | SELL | 2024-05-16 | 2024-05-20 | $77.99 | $429K | -0.5% | +1.7% | +7.9% |
| LMAT | SELL | 2023-06-02 | 2023-06-05 | $64.24 | $321K | +3.5% | -0.1% | -14.9% |
| LMAT | SELL | 2023-02-27 | 2023-03-01 | $49.27 | $345K | -4.2% | +2.9% | +23.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.